Solid Biosciences is trading at $8.65 (-5.98%) with no major company-specific announcement identified for August 17, 2026.
- The latest notable developments are the August 6 second-quarter update and filing for a potential $200 million stock offering, both predating the move.
- Broader markets were modestly firmer; the decline remains unexplained pending additional news or filings.